Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ATRA holding history

Atara Biotherapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATRA overviewAll 13F holders of ATRAFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ATRA by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−30,040−100.0%Sold outHolders
Q4 202530,040$543.4K<0.1%+11,104+58.6%AddedHolders
Q3 202518,936$271.4K<0.1%+2,000+11.8%AddedHolders
Q2 202516,936$130.7K<0.1%−500−2.9%ReducedHolders
Q1 202517,436$103.6K<0.1%−49,704−74.0%ReducedHolders
Q4 202467,140$893.6K<0.1%−594−0.9%ReducedHolders
Q3 202467,734$550.7K<0.1%+21,670+47.0%AddedHolders
Q2 202446,064$391.5K<0.1%+6,849+17.5%AddedConverted for a 1-for-25 splitHolders
Q1 2024980,385$680.0K<0.1%+357,474+57.4%AddedHolders
Q4 2023622,911$319.0K<0.1%−206,200−24.9%ReducedHolders
Q3 2023829,111$1.23M<0.1%−1,287,789−60.8%ReducedHolders
Q2 20232,116,900$3.41M<0.1%+679,200+47.2%AddedHolders
Q1 20231,437,700$4.17M<0.1%+1,272,700+771.3%AddedHolders
Q4 2022165,000$541.0K<0.1%−171,100−50.9%ReducedHolders
Q3 2022336,100$1.27M<0.1%+110,900+49.2%AddedHolders
Q2 2022225,200$1.75M<0.1%−344,600−60.5%ReducedHolders
Q1 2022569,800$5.29M<0.1%+569,800NewHolders
Q4 20210$00.0%−281,679−100.0%Sold outHolders
Q3 2021281,679$5.04M<0.1%−617,021−68.7%ReducedHolders
Q2 2021898,700$14.0M<0.1%+372,600+70.8%AddedHolders
Q1 2021526,100$7.55M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.